Over the past four years, INCATE has been supporting early-stage ventures working on innovations to address the challenge of antimicrobial resistance (AMR). INCATE's portfolio spans a wide range of innovative solutions, and the progress of [...]
More news
On February 7, 2025, Swiss biopharmaceutical innovator BioVersys made its debut on the SIX Swiss [...]
On the evening of April 9, 2025, The Voltahalle in Basel was the stage of [...]
AdjuTec Pharma AS - 3rd place winner of the Poster Competition at the 9th AMR [...]
INCATE kicked off the AMR week in Basel with the INCATE Networking Event on February [...]
Our colleague Helmut Kessmann has decided his time has come to retire and embark on new [...]
The INCATE Selection Committee selected the new 4 ventures for Stage I support. Meet the [...]
The AMR Conference 2025 has reached another milestone as the finalists for this year’s Poster [...]
A&J Science, an innovative biotech company based in South Korea and dedicated to addressing AMR, [...]
